Efficacy and safety of radiofrequency catheter ablation in hypertrophic cardiomyopathy patients combined with atrial fibrillation with different risks of sudden cardiac death

Chen-xi YANG,Xu LIU,Wei-feng JIANG,Yu ZHANG,Ying-jia XU,Yi-qing YANG

DOI: https://doi.org/10.12025/j.issn.1008-6358.2017.20170349

2017-01-01

Abstract:Objective:To compare the safety and efficacy of radiofrequency catheter ablation in hypertrophic cardiomyopathy(HCM)patients with atrial fibrillation(AF)with different risks of sudden cardiac death(SCD).Methods:From 85 hypertrophic cardiomyopathy patients with AF,63 AF type-matched patients were selected.According to the HCM Risk-SCD risk prediction model,63 HCM patients combined with AF were divided into high-risk group(middle and high sudden death risk group,n=18)and low risk group(low sudden death risk group,n=45).The clinical data of both groups of patients were collected and the long-term prognosis of radiofrequency catheter ablation was compared.Objective:The mean follow-up period was(41.7±36.4)months.The successful rate of the first ablation in the high-risk group was significantly lower than that in the low-risk group(22.2％vs 53.3％,P=0.021).The long-term prognosis after repeated ablation in the high-risk group was also worse than that in the low-risk group death(33.3％vs 73.3％,P=0.003).There was no significant difference in postoperative complications and mortality between the two groups.Multivariate regression analysis showed that the left atrial diameter(OR=1.915,95％CI 1.071-3.445,P=0.006)and the 5-year SCD risk(OR=2.901,95％CI 1.203-4.679,P=0.008)were independent predictors on recurrence after ablation.Conclusions:The effectiveness of the first AF ablation and the long-term prognosis of repeated ablation in the HCM patients with high SCD risks are significantly lower than those in the HCM patients with low SCD risks.For them,AF radiofrequency ablation,especially repeated ablation,should be considered in combination with surgical risks and clinical benefits.